Your Basket's Financial Footprint
Summary of market cap composition for the Pharma basket.
- Large-cap dominance suggests generally lower volatility and more stable returns, closely tracking broad market healthcare performance.
- Suitable as a core, long-term holding for diversified portfolios rather than a speculative or high-conviction growth position.
- Expect steady, incremental appreciation over time; less likely to deliver explosive short-term gains.
JNJ: $462.30B
PFE: $141.29B
MRNA: $10.74B
- Other
About This Group of Stocks
Our Expert Thinking
Pharmaceutical companies offer a unique combination of stability and growth potential. With consistent demand for healthcare and ongoing innovation in treatments, this industry is projected to grow at 7% annually, reaching $1.9 trillion by 2027.
What You Need to Know
These pharma stocks represent companies focused on developing life-improving and life-saving medications. The healthcare sector tends to be more resilient during economic downturns, as medical needs remain constant regardless of market conditions.
Why These Stocks
This collection includes established pharmaceutical giants alongside innovative biotech companies. These stocks were selected based on their market leadership, research capabilities, and potential for growth through new treatments and medications.
Why You'll Want to Watch These Stocks
Healthcare's Golden Opportunity
The pharma industry is expected to reach $1.9 trillion by 2027. Getting in now means you could benefit from this massive growth trajectory as companies develop new treatments.
Innovation Worth Watching
Companies like Moderna and Novavax showed how pharmaceutical breakthroughs can lead to extraordinary gains. These stocks represent the future of healthcare innovation.
Recession-Resistant Potential
Healthcare needs remain constant regardless of economic conditions, making pharma stocks potentially more stable during market downturns while still offering growth.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Cybersecurity Investment Surge After Breach Explained
The U.S. Treasury has cancelled its contracts with Booz Allen Hamilton following a major data breach, signaling a new era of accountability for government contractors. This move is expected to drive significant investment into specialized cybersecurity and data protection firms as agencies seek to secure their sensitive information.
Meta Subscriptions: What's Next for Social Media?
Meta is introducing premium subscriptions for its apps, signaling a major shift away from relying solely on ad revenue. This theme focuses on companies poised to benefit as the social media industry increasingly adopts paid, feature-based subscription models.
Auto Supply Chain Stability Explained
Ford and GM are negotiating a rescue package for a key parts supplier, highlighting the critical need for stability in the automotive supply chain. This creates an investment opportunity in financially robust suppliers that are essential to vehicle production.